1 day Pharma Stock Roundup: EU Nod for PFE’s Hympavzi, NVS Ups Sales ViewZacks
EU approval for PFE’s hemophilia drug Hympavzi. Novartis upgrades its mid-term sales guidance.
XEU approval for PFE’s hemophilia drug Hympavzi. Novartis upgrades its mid-term sales guidance.
X